Post Doctoral Fellow
Genome Institute of Singapore, Singapore
Peiyong is interested in dissecting the interplays of epigenomics and genomic dysregulations in oncogenesis, metastasis, and drug resistance through multi-omics integration and drug screening, with a focus on rare cancers. He worked on epigenomic and genomic alterations in non-clear cell renal cell carcinoma and ameloblastoma during his graduate studies at Duke-NUS Medical School, with help and supervision from Prof. Teh.